Mar 09, 2012 / Fact Sheets

Fact sheet on March 2012 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans

Mar 09, 2012 / Transcripts

March 2012 meeting transcript

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Post-Acute Care, Private Plans, Regional Issues

Mar 09, 2012 / Presentations

Medicare coverage of and payment for home infusion therapy

Research Areas:

Drugs, Devices, and Tests, Private Plans

Mar 01, 2012 / Chapters

Appendix A: Commissioners’ voting on recommendations (March 2012 report)

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Quality

Mar 01, 2012 / Chapters

Chapter 13: Status report on Part D, with focus on beneficiaries with high drug spending (March 2012 report)

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans

Feb 29, 2012 / Meeting Brief

Medicare coverage of and payment for home infusion therapy

Research Areas:

Drugs, Devices, and Tests, Private Plans

Feb 29, 2012 / Comment Letters

MedPAC comment on CMS’s Advance Notice of Methodological Changes for Calendar Year (CY) 2013 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2013 Call Letter

Research Areas:

Private Plans, Quality

Jan 13, 2012 / Presentations

Encouraging the use of lower-cost medications by beneficiaries receiving Part D’s low-income subsidy

Research Areas:

Private Plans

Dec 15, 2011 / Presentations

Encouraging the use of lower-cost medications by beneficiaries receiving Part D’s low-income subsidy

Research Areas:

Drugs, Devices, and Tests, Private Plans

Nov 04, 2011 / Presentations

Status report on Part D, with focus on beneficiaries with high drug spending

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans